Michael Hombach

2.8k total citations
51 papers, 2.0k citations indexed

About

Michael Hombach is a scholar working on Clinical Biochemistry, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Michael Hombach has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Clinical Biochemistry, 24 papers in Infectious Diseases and 24 papers in Molecular Medicine. Recurrent topics in Michael Hombach's work include Bacterial Identification and Susceptibility Testing (31 papers), Antibiotic Resistance in Bacteria (24 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Michael Hombach is often cited by papers focused on Bacterial Identification and Susceptibility Testing (31 papers), Antibiotic Resistance in Bacteria (24 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Michael Hombach collaborates with scholars based in Switzerland, Germany and France. Michael Hombach's co-authors include Erik C. Böttger, Guido V. Bloemberg, Reinhard Zbinden, Bettina Schulthess, Silke Polsfuß, Vera Meyer, Stefan P. Kuster, Florian P. Maurer, Małgorzata Roos and Peter M. Keller and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Clinical Microbiology.

In The Last Decade

Michael Hombach

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Hombach Switzerland	27	745	681	605	561	332	51	2.0k
Beatriz Meurer Moreira Brazil	28	1.0k 1.4×	410 0.6×	630 1.0×	404 0.7×	605 1.8×	75	2.1k
Kang Liao China	24	1.1k 1.4×	318 0.5×	649 1.1×	668 1.2×	348 1.0×	77	2.0k
Jeong Hwan Shin South Korea	25	599 0.8×	404 0.6×	661 1.1×	721 1.3×	483 1.5×	149	2.0k
Georgia Vrioni Greece	28	1.2k 1.7×	378 0.6×	614 1.0×	695 1.2×	287 0.9×	77	2.3k
Evgeny A. Idelevich Germany	25	566 0.8×	894 1.3×	734 1.2×	592 1.1×	413 1.2×	82	2.0k
Jeannete Zurita Ecuador	24	471 0.6×	421 0.6×	1.1k 1.8×	608 1.1×	404 1.2×	75	1.8k
Nicolas Fortineau France	27	1.0k 1.4×	407 0.6×	524 0.9×	243 0.4×	513 1.5×	55	1.9k
Esther Culebras Spain	24	663 0.9×	344 0.5×	491 0.8×	493 0.9×	328 1.0×	90	1.7k
Tsai‐Ling Lauderdale Taiwan	30	1.1k 1.5×	292 0.4×	696 1.2×	649 1.2×	579 1.7×	63	2.3k
Yih‐Ru Shiau Taiwan	23	813 1.1×	265 0.4×	418 0.7×	389 0.7×	401 1.2×	32	1.5k

Countries citing papers authored by Michael Hombach

Since Specialization

Citations

This map shows the geographic impact of Michael Hombach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hombach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hombach more than expected).

Fields of papers citing papers by Michael Hombach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hombach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hombach. The network helps show where Michael Hombach may publish in the future.

Co-authorship network of co-authors of Michael Hombach

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hombach. A scholar is included among the top collaborators of Michael Hombach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hombach. Michael Hombach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bambeke, Françoise Van, et al.. (2020). Increased Azithromycin Susceptibility of Multidrug-Resistant Gram-Negative Bacteria on RPMI-1640 Agar Assessed by Disk Diffusion Testing. Antibiotics. 9(5). 218–218. 19 indexed citations

Wolfensberger, Aline, et al.. (2019). The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods. Antimicrobial Resistance and Infection Control. 8(1). 193–193. 50 indexed citations

Maurer, Florian P., Dawn Sievert, Doris Hillemann, et al.. (2018). Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex. Clinical Microbiology and Infection. 25(3). 379.e1–379.e7. 42 indexed citations

Hombach, Michael, et al.. (2017). Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study. Journal of Antimicrobial Chemotherapy. 72(6). 1659–1668. 35 indexed citations

Bloemberg, Guido V., et al.. (2017). Evaluation of the AID carbapenemase line probe assay for rapid detection and identification of carbapenemase genes in Gram-negative bacilli. Journal of Antimicrobial Chemotherapy. 72(7). 1948–1954. 8 indexed citations

Hombach, Michael, et al.. (2017). Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6–8 h by automated disc diffusion antibiotic susceptibility testing. Journal of Antimicrobial Chemotherapy. 72(11). 3063–3069. 15 indexed citations

Hombach, Michael, et al.. (2016). Comparison of phenotypic methods for the detection of penicillinase inStaphylococcus aureusand proposal of a practical diagnostic approach. Journal of Antimicrobial Chemotherapy. 72(4). dkw521–dkw521. 6 indexed citations

Hombach, Michael, et al.. (2015). Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing. Journal of Antimicrobial Chemotherapy. 71(1). 141–151. 26 indexed citations

Hombach, Michael, Patrice Courvalin, & Erik C. Böttger. (2014). Validation of Antibiotic Susceptibility Testing Guidelines in a Routine Clinical Microbiology Laboratory Exemplifies General Key Challenges in Setting Clinical Breakpoints. Antimicrobial Agents and Chemotherapy. 58(7). 3921–3926. 14 indexed citations

10.

Broecker, Felix, Michael Kube, Jochen Klumpp, et al.. (2013). Analysis of the Intestinal Microbiome of a Recovered <b><i>Clostridium difficile</i></b> Patient after Fecal Transplantation. Digestion. 88(4). 243–251. 29 indexed citations

11.

Hombach, Michael, Reinhard Zbinden, & Erik C. Böttger. (2013). Standardisation of disk diffusion results for antibiotic susceptibility testing using the sirscan automated zone reader. BMC Microbiology. 13(1). 225–225. 78 indexed citations

12.

Bloemberg, Guido V., Silke Polsfuß, Vera Meyer, Erik C. Böttger, & Michael Hombach. (2013). Evaluation of the AID ESBL line probe assay for rapid detection of extended-spectrum β-lactamase (ESBL) and KPC carbapenemase genes in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 69(1). 85–90. 15 indexed citations

13.

Hombach, Michael, Ákos Somoskövi, Rico Hömke, Claudia Ritter, & Erik C. Böttger. (2013). Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST. International Journal of Medical Microbiology. 303(5). 270–276. 19 indexed citations

14.

Hombach, Michael, et al.. (2013). Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates. Journal of Antimicrobial Chemotherapy. 68(9). 2092–2098. 35 indexed citations

15.

Hombach, Michael, Aline Wolfensberger, Stefan P. Kuster, & Erik C. Böttger. (2013). Influence of Clinical Breakpoint Changes from CLSI 2009 to EUCAST 2011 Antimicrobial Susceptibility Testing Guidelines on Multidrug Resistance Rates of Gram-Negative Rods. Journal of Clinical Microbiology. 51(7). 2385–2387. 20 indexed citations

16.

Hombach, Michael, Erik C. Böttger, & Małgorzata Roos. (2012). The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clinical Microbiology and Infection. 19(2). E59–E71. 40 indexed citations

17.

Keller, Peter M., et al.. (2012). Vancomycin-resistantEnterococcus. Swiss Medical Weekly. 142(2122). w13540–w13540. 14 indexed citations

18.

Polsfuß, Silke, et al.. (2011). Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae. Clinical Microbiology and Infection. 18(12). 1194–1204. 34 indexed citations

19.

Hombach, Michael, Guido V. Bloemberg, & Erik C. Böttger. (2011). Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. Journal of Antimicrobial Chemotherapy. 67(3). 622–632. 96 indexed citations

20.

Peter, Silke, Silke Polsfuß, Michael Hombach, et al.. (2011). Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis. Journal of Clinical Microbiology. 49(8). 2924–2932. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact